Pharmaceutical Industry : African pharma firms join global vaccine manufacturer to produce mRNA vaccines

On July 21, 2025, Africa advances in pharmaceutical manufacturing as BioNTech partners with firms in South Africa and Senegal to produce mRNA vaccines for global use. This strategic collaboration aims to strengthen regional health security and reduce dependence on imports. The move marks Africa’s entry into advanced pharma production and positions the continent as a critical player in future pandemic preparedness and global vaccine supply chains.